0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Basaglar"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$4,490USDGBP
Basal Insulin - Global Strategic Business Report - Product Thumbnail Image

Basal Insulin - Global Strategic Business Report

  • Report
  • July 2025
  • 179 Pages
  • Global
From
EUR$5,850USDGBP
From
EUR$4,750USDGBP
US Biosimilar Insulin Market Opportunity & Clinical Trials Insight 2026 - Product Thumbnail Image

US Biosimilar Insulin Market Opportunity & Clinical Trials Insight 2026

  • Report
  • August 2021
  • 50 Pages
  • United States
From
EUR$2,160USDGBP
EUR$2,400USDGBP
United States Diabetes Market Report: 2024-2032 - Product Thumbnail Image

United States Diabetes Market Report: 2024-2032

  • Report
  • July 2024
  • 139 Pages
  • United States
From
EUR$2,999USDGBP
Insulin Glargine- - Biosimilar Insight, 2022 - Product Thumbnail Image

Insulin Glargine- - Biosimilar Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
EUR$2,000USDGBP
From
EUR$3,450USDGBP
From
EUR$3,450USDGBP
From
EUR$3,450USDGBP
From
EUR$3,450USDGBP
From
EUR$3,450USDGBP
From
EUR$4,450USDGBP
From
EUR$4,750USDGBP
From
EUR$4,750USDGBP
From
EUR$4,750USDGBP
From
EUR$4,750USDGBP
From
EUR$4,750USDGBP
From
EUR$4,750USDGBP
Loading Indicator

Basaglar is a type of endocrine and metabolic disorder drug used to treat type 1 and type 2 diabetes. It is a long-acting insulin analog that helps to control blood sugar levels. It works by mimicking the action of natural insulin in the body, helping to reduce the amount of sugar in the blood. Basaglar is administered through an injection, either subcutaneously or intramuscularly. It is typically taken once a day, although the dosage may vary depending on the individual's needs. Basaglar is a relatively new drug, having been approved by the FDA in 2014. It is marketed by Eli Lilly and Company, and is available in both the United States and Europe. Other companies that produce similar drugs include Novo Nordisk, Sanofi, and Merck. Basaglar is also available in generic form, with several generic manufacturers offering the drug. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more